000 01148 a2200277 4500
005 20250514002621.0
264 0 _c20011214
008 200112s 0 0 eng d
022 _a1040-8428
024 7 _a10.1016/s1040-8428(01)00108-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGoldenberg, D M
245 0 0 _aThe role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: the coming of age of radioimmunotherapy.
_h[electronic resource]
260 _bCritical reviews in oncology/hematology
_c
300 _a195-201 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntibodies, Neoplasm
_xtherapeutic use
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aIodine Radioisotopes
650 0 4 _aLymphoma, Non-Hodgkin
_xradiotherapy
650 0 4 _aRadioimmunotherapy
_xmethods
773 0 _tCritical reviews in oncology/hematology
_gvol. 39
_gno. 1-2
_gp. 195-201
856 4 0 _uhttps://doi.org/10.1016/s1040-8428(01)00108-1
_zAvailable from publisher's website
999 _c11348091
_d11348091